ESC 365 - Secondary mitral regurgitation requires invasive therapy to improve outcome

ESC Premium Access

Secondary mitral regurgitation requires invasive therapy to improve outcome

Event: ESC CONGRESS 2017

Topic: Mitral valve disease

Session type: Debate Session

Date: 29 August 2017

Time: 08:30 - 10:00

Congress Session

8 presentations in this session

Opening question.

Positioning of the topic - Secondary mitral regurgitation - Pathophisiology and treatment options

Speaker: Professor R. Hahn (New York, US)

Secondary mitral regurgitation requires invasive therapy to improve outcome - PRO

Speaker: Professor F. Maisano (Milano, IT)

Secondary mitral regurgitation requires invasive therapy to improve outcome - CON

Speaker: Professor A. Hagendorff (Leipzig, DE)

Secondary mitral regurgitation requires invasive therapy to improve outcome - Rebuttal PRO

Speaker: Professor F. Maisano (Milano, IT)

Secondary mitral regurgitation requires invasive therapy to improve outcome - Rebuttal CON

Speaker: Professor A. Hagendorff (Leipzig, DE)

Chairperson closing question.

Speaker: Professor A. Vahanian (Paris, FR)

Secondary mitral regurgitation requires invasive therapy to improve outcome - Moderated discussion

6 speakers from this session

Professor Rebecca Hahn

Columbia University Medical Center, New York (United States of America)

26 presentations

2 followers

Professor Francesco Maisano

Ospedale San Raffaele, Milano (Italy)

41 presentations

2 followers

Professor Andreas Hagendorff

University of Leipzig, Leipzig (Germany)

15 presentations

1 follower

Professor Francesco Maisano

Ospedale San Raffaele, Milano (Italy)

41 presentations

2 followers

Professor Andreas Hagendorff

University of Leipzig, Leipzig (Germany)

15 presentations

1 follower

Professor Alec Vahanian

University Paris-Descartes, Paris (France)

31 presentations

14 followers

This platform is supported by